James MD - Therapeutic Solutions Vice Officer
| TSOI Stock | USD 0.0003 0.0001 25.00% |
Insider
James MD is Vice Officer of Therapeutic Solutions International
| Age | 59 |
| Phone | 760 295 7208 |
| Web | https://www.therapeuticsolutionsint.com |
Therapeutic Solutions Management Efficiency
The company has return on total asset (ROA) of (0.7558) % which means that it has lost $0.7558 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (12.2676) %, meaning that it created substantial loss on money invested by shareholders. Therapeutic Solutions' management efficiency ratios could be used to measure how well Therapeutic Solutions manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Showing other executives | INSIDER Age | ||
| LaBella MS | ZyVersa Therapeutics | 66 | |
| Pr Sorek | Biomx Inc | N/A | |
| Darren Lui | Aptorum Group Ltd | 42 | |
| Chung Huen | Aptorum Group Ltd | 45 | |
| Assaf Oron | Biomx Inc | 50 | |
| Karen Cashmere | ZyVersa Therapeutics | 73 | |
| Pablo MD | ZyVersa Therapeutics | N/A | |
| Clark Cheng | Aptorum Group Ltd | 44 | |
| Linda Pestano | Ensysce Biosciences | 56 | |
| MSE MBA | Ensysce Biosciences | 52 | |
| Inbal BenjaminiElran | Biomx Inc | N/A | |
| Eran MD | Biomx Inc | N/A | |
| Merav Bassan | Biomx Inc | 59 | |
| Inbar GahaliSass | Biomx Inc | N/A | |
| Geoffrey Birkett | Ensysce Biosciences | 62 | |
| Wai Lee | Aptorum Group Ltd | 50 | |
| Jonathan MBA | Biomx Inc | 48 | |
| Jeffrey Millard | Ensysce Biosciences | 49 | |
Management Performance
| Return On Equity | -12.27 | |||
| Return On Asset | -0.76 |
Therapeutic Solutions Leadership Team
Elected by the shareholders, the Therapeutic Solutions' board of directors comprises two types of representatives: Therapeutic Solutions inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Therapeutic. The board's role is to monitor Therapeutic Solutions' management team and ensure that shareholders' interests are well served. Therapeutic Solutions' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Therapeutic Solutions' outside directors are responsible for providing unbiased perspectives on the board's policies.
| James MD, Vice Officer | ||
| Serena Robella, Director Sales | ||
| Timothy Dixon, Chairman, CEO and Pres | ||
| Feng Lin, Chief Officer |
Therapeutic Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right pink sheet is not an easy task. Is Therapeutic Solutions a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -12.27 | |||
| Return On Asset | -0.76 | |||
| Operating Margin | (13.37) % | |||
| Current Valuation | 21.6 M | |||
| Shares Outstanding | 2.61 B | |||
| Shares Owned By Insiders | 27.98 % | |||
| Price To Earning | (8.00) X | |||
| Price To Book | 11.55 X | |||
| Price To Sales | 81.80 X | |||
| Revenue | 145.96 K |
Currently Active Assets on Macroaxis
Other Information on Investing in Therapeutic Pink Sheet
Therapeutic Solutions financial ratios help investors to determine whether Therapeutic Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Therapeutic with respect to the benefits of owning Therapeutic Solutions security.